Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) shares, rose in value, with the stock price down by -1.10% to the previous day’s close as strong demand from buyers drove the stock to $8.06.
Actively observing the price movement in the last trading, the stock closed the session at $8.15. Referring to stock’s 52-week performance, its high was $15.70, and the low was $8.07. On the whole, IRWD has fluctuated by -6.50% over the past month.
As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $0.2, which is expected to increase to $0.37 for fiscal year $0.68 and then to about $0.81 by fiscal year 2025. Data indicates that the EPS growth is expected to be 110.50% in 2025, while the next year’s EPS growth is forecast to be 19.10%.
Analysts have estimated the company’s revenue for the quarter at $106.3 million, with a low estimate of $102.1 million and a high estimate of $111.7 million. According to the average forecast, sales growth in current quarter could jump up 5.90%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $448.27 million, representing an increase of 1.30% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that IRWD’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 50% Buy while long term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of IRWD currently trading nearly -7.11% and -31.23% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 29.75, while the 7-day volatility ratio is showing 3.30% which for the 30-day chart, stands at 4.37%. Furthermore, Ironwood Pharmaceuticals Inc (IRWD)’s beta value is 0.56, and its average true range (ATR) is 0.46.
A comparison of Ironwood Pharmaceuticals Inc (IRWD) with its peers suggests the former has fared considerably weaker in the market. IRWD showed an intraday change of -1.10% in last session, and over the past year, it shrunk by -23.67%%.
Data on historical trading for Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) indicates that the trading volumes over the past 10 days have averaged 2.97 million and over the past 3 months, they’ve averaged 4.90 million. According to company’s latest data on outstanding shares, there are 156.35 million shares outstanding.
Nearly 3.15% of Ironwood Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 107.14% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 18.77 million shares as on Mar 15, 2024, resulting in a short ratio of 2.46. According to the data, the short interest in Ironwood Pharmaceuticals Inc (IRWD) stood at 11.99% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 15.6 million. The stock has fallen by -29.55% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IRWD stock heading into the next quarter.
